Risedronate sodium

Product description

Therapeutic Area: Musculo-skeletal system
  • EU DMF available
  • US DMF no. 20384 available
  • Japanese DMF available
  • CEP available


Indication: Risedronate sodium is a pyridinyl bisphosphonate that inhibits osteoclast-mediated bone resorption and modulates bone metabolism.


Read more

Specifications

CAS Registry Number 115436-72-1
Categories APIs (Active Pharmaceutical Ingredients)
Sales markets Western Europe; Eastern Europe; Middle East Region (e.g. UAE); Asia; Oceania; North America (USA, Canada); Central/South America
Supplied from Poland
Measured In g; Kg

More products from ZF Polpharma SA

View all our products (51)

Products from other suppliers